Evidence map›Paper›PMID 31098645›Full record

ReviewDer Internist2019

[Traveling with immunodeficiency-Problems and prevention].

J Lutz, A Rieke, B Rieke

Abstract readReview
PubMed Publisher
In one paragraph

Review in Der Internist, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 94% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

J LutzKlinik für Innere Medizin - Nephrologie und Infektiologie, Gemeinschaftsklinikum Mittelrhein Kemperhof Koblenz, Koblenzer Straße 115-155, 56073, Koblenz, Deutschland. jens.lutz@gk.de.
A RiekeKlinik für Innere Medizin - Nephrologie und Infektiologie, Gemeinschaftsklinikum Mittelrhein Kemperhof Koblenz, Koblenzer Straße 115-155, 56073, Koblenz, Deutschland.
B RiekePraxis für Tropenmedizin, Reisemedizin und Allgemeinmedizin, Düsseldorf, Deutschland.
Gemeinschaftsklinikum Mittelrhein · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Advances in medical care have led to an increasing number of immunocompromised travellers. Travellers with immunodeficiencies have a higher risk of infections and can acquire infectious diseases that are rare in immunocompetent travellers. Of central interest are travellers' diarrhea, diseases of the respiratory tract, tuberculosis and inhalative mycoses as well as diseases transmitted by vectors such as malaria. For every such journey a timely consultation in travel medicine is indicated. First the individual risk must be assessed according to the degree of immunodeficiency. An individual counselling is then related to the itinerary, the travel destination and any activities planned. This information is the basis for an individual set of prophylactic measures with respect to infections and other risks through certain modes of behavior, medication, and vaccinations. Post-travel counselling and evaluation are equally important. This requires physicians experienced in both immunosuppression and travel medicine.

Indexed as

Immunocompromised HostTravelDiarrheaHumansMalariaTravel MedicineVaccinationDisease vectorsImmunosuppressionMalariaTraveller’s diarrheaTravel medicine

Identifiers

PMID31098645
OpenAlexW2945347535

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.